Aloop Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 43257498
Ole Maaløes Vej 3, 2200 København N
Income statement (kDKK)
2022 | 2023 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | -4 550.21 | -9 058.29 |
| Employee benefit expenses | - 815.57 | -2 845.93 |
| EBIT | -5 365.78 | -11 904.22 |
| Other financial income | 384.51 | |
| Other financial expenses | -22.02 | -4.45 |
| Pre-tax profit | -5 387.80 | -11 524.16 |
| Income taxes | 1 219.05 | 2 715.25 |
| Net earnings | -4 168.75 | -8 808.92 |
Assets (kDKK)
2022 | 2023 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Other receivables | 6.74 | |
| Investments total | 6.74 | |
| Long term receivables total | ||
| Inventories total | ||
| Current amounts owed by group member comp. | 1 219.95 | 2 701.17 |
| Current other receivables | 613.40 | 731.22 |
| Short term receivables total | 1 833.35 | 3 432.39 |
| Cash and bank deposits | 11 608.62 | 30 810.95 |
| Cash and cash equivalents | 11 608.62 | 30 810.95 |
| Balance sheet total (assets) | 13 441.97 | 34 250.09 |
Equity and liabilities (kDKK)
2022 | 2023 | |
|---|---|---|
| Share capital | 100.00 | 300.00 |
| Retained earnings | 14 900.00 | 40 531.25 |
| Profit of the financial year | -4 168.75 | -8 808.92 |
| Shareholders equity total | 10 831.25 | 32 022.34 |
| Non-current liabilities total | ||
| Current trade creditors | 2 425.32 | 1 609.29 |
| Other non-interest bearing current liabilities | 185.40 | 618.47 |
| Current liabilities total | 2 610.72 | 2 227.75 |
| Balance sheet total (liabilities) | 13 441.97 | 34 250.09 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.